StockData
Integra LifeSciences Holdings Corp logo

Integra LifeSciences Holdings Corp (IART) KPIs and segments

IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/308% below fair value
$13.55−0.43 (-3.08%)

Close on Nov 17, 2026Market cap $1.05BP/E 79.7Yield –

KPIs & segments

Operating metrics and segments that drive Integra LifeSciences's business

Integra LifeSciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Specialty Surgery($M)5
304309283323293304281315271302256272
Neurosurgery($M)
214213198226202209191220176206202210
Surgical Instruments($M)
49.754.850.253.1
Instruments($M)
47.252.350.253.151.051.054.254.544.451.1
ENT Solutions($M)
40.441.240.941.9
ENT($M)
37.744.840.941.938.843.540.641.79.7910.3
Tissue Technologies($M)2
112109112102128110116112125
Wound Reconstruction and Care($M)
80.084.084.774.810280.587.780.993.9
Private Label($M)
31.625.526.927.226.529.628.731.631.6
Tissue Reconstruction($M)4
107109109109112102
Wound Reconstruction Solutions($M)
81.581.384.084.7
Wound Reconstruction and Care($M)
79.674.8
Private Label($M)
28.229.126.927.2
Corporate Partnerships($M)
25.525.5
United States($M)
299307289320296306282336290310256283
Asia Pacific($M)
47.948.745.253.742.747.745.144.137.146.049.546.1
Europe($M)
42.342.640.041.942.942.635.341.834.440.741.645.2
Rest of World($M)
21.620.417.419.020.619.020.020.719.221.321.522.6
Specialty Surgery($M)
90.888.983.114388.8-30272.2136101164103118
Tissue Technologies($M)
30.127.1-10516.042.828.537.230.741.9
Tissue Reconstruction($M)
15.518.920.311.4-1194.44
Specialty Surgery($M)
177179173213179184171212175209163
Tissue Technologies($M)
69.166.860.956.985.069.575.074.9
Tissue Reconstruction($M)
65.367.571.360.555.052.7

28 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-10-23.

See a number that looks wrong?